A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis	Skin and Connective Tissue Diseases, connective tissue disorder, skin disorder, systemic sclerosis	Active, not recruiting	Phase 4	2026-01-27		NCT05300932

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Eli Lilly and Company	370
Johns Hopkins University	579
Renmin Hospital of Wuhan University	73
Tongji Hospital	276
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	319

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of RheumatologyTongji Hospital	Wuhan	China	2
Tongji Hospital	Wuhan	China	49